QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention 期刊论文 THROMBOSIS RESEARCH, 2018, 卷号: 170, 页码: 142-147 作者:  Bai, Xiao-Fang;  Zhang, Ya-Ping;  Zhou, Juan;  Wu, Yue;  Li, Rui-Feng 收藏  |  浏览/下载：4/0  |  提交时间：2019/11/19 Prognosis  Risk factor  GRACE score  CYP2C19 metabolizer  Acute coronary syndrome   Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention 期刊论文 THROMBOSIS RESEARCH, 2018, 卷号: Vol.170, 页码: 142-147 作者:  Bai, Xiao-Fang;  Zhang, Ya-Ping;  Zhou, Juan;  Wu, Yue;  Li, Rui-Feng 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/26 Acute  coronary  syndrome  CYP2C19  metabolizer  GRACE  score  Risk  factor  Prognosis   Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of cyp2c19 and cyp2d6 in han chinese 期刊论文 Pharmacogenomics journal, 2009, 卷号: 9, 期号: 6, 页码: 380-394 作者:  Zhou, Q.;  Yu, X. M.;  Lin, H. B.;  Wang, L.;  Yun, Q. Z. 收藏  |  浏览/下载：14/0  |  提交时间：2019/05/10 Cyp2c19  Cyp2d6  Han chinese  Genetic polymorphism   The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers 期刊论文 European Journal of Clinical Pharmacology, 2009, 卷号: 65, 期号: 3, 页码: 281-285 作者:  Wang, Guo;  Lei, He-Ping;  Li, Zhi;  Tan, Zhi-Rong;  Guo, Dong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03 CYP2C19  Genotype  Pharmacokinetics  Voriconazole   Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects 期刊论文 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 卷号: 64, 期号: 1, 页码: 67-74 作者:  Zhang, Yifan;  Si, Dayong;  Chen, Xiaoyan;  Lin, Nan;  Guo, Yingjie 收藏  |  浏览/下载：21/0  |  提交时间：2019/01/08 clinical pharmacokinetics  CYP2C19  CYP2C9  gliclazide  polymorphism